Table 1.
VMAT2 WT and LO mice exposed to 30 mg/kg DE-71 for 30 days show an increase in brain concentrations of PBDE congeners.
BDE-28 | BDE-47 | BDE-66 | BDE-85 | BDE-99 | BDE-100 | BDE-153 | BDE-154 | |
---|---|---|---|---|---|---|---|---|
WTCTL | 0+0 | 0.004+0.004 | 0+0 | 0+0 | 0.01+0.003 | 0+0 | 0+0 | 0+0 |
LOCTL | 0+0 | 0.01+0.01 | 0+0 | 0+0 | 0+0 | 0+0 | 0+0 | 0+0 |
WT DE-71 | 0+0 | 1.00+0.52 | 0.01+0.01 | 0.07+0.03 | 1.70+0.63 | 0.41+0.17 | 1.78+0.16 | 0.10+0.04 |
LO DE-71 | 0+0 | 0.19+0.08 | 0+0 | 0.03+.002 | 0.67+0.12 | 0.17+0.07 | 1.52+0.16 | 0.05+0.01 |
Data are expressed as mean ± SEM (4–6 animals per treatment group). Data are presented as mean PBDE congener levels (μg/g wet weight).